Piperonyl Butoxide

Piperonyl Butoxide

SCHEMBL489855

CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2.[BaH2]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

82298078230507823050882308198230924823093782309578231029823151182323108232678823291582336198233620823362182338238234154823440782344088234840823547582360878236088823610082369748237447823761882377958238085823808682383438238380823840482399208240195

The experimentally established mechanism targets of Piperonyl Butoxide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.97
ALDH1A1 P00352 4/20 0.97
TSHR P16473 1/20 0.97
HPGD P15428 2/20 0.44
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C19 P33261 3/20 0.37
CYP2C9 P11712 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
SCN1A P35498 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN3A Q9NY46 1/20 0.35
HTT P42858 2/20 0.34
MAOB P27338 2/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperonyl Butoxide SCHEMBL2997422 0.99 CYP3A4 (0.94) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL1517385 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL29386186 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
SCHEMBL9958244 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL6561910 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL5490 0.98 CYP3A4 (1.00) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL11895771 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL9155914 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL4809313 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1
Piperonyl Butoxide SCHEMBL1654891 0.97 CYP3A4 (0.97) CYP3A4ALDH1A1TSHRHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120091406-A1 NANOCRYSTAL-METAL OXIDE-POLYMER COMPOSITES AND PREPARATION METHOD THEREOF SAMSUNG ELECTRONICS CO., LTD. (KR) 2012-04-19 US claimed
EP-1585714-B1 PROCESSES FOR THE PREPARATION OF HIGHER MOLECULAR WEIGHT KETONES EASTMAN CHEM CO (US) 2010-08-04 EP claimed
US-7071361-B2 Processes for the preparation of high molecular weight saturated ketones FASTMAN CHEMICAL COMPANY (US) 2006-07-04 US claimed
EP-1638913-A1 PROCESSES FOR PREPARING BETA-HYDROXY-KETONES AND ALPHA, BETA-UNSATURATED KETONES EASTMAN CHEMICAL COMPANY (US) 2006-03-29 EP claimed
EP-1616850-A1 Processes for the preparation of higher molecular weight saturated ketones in the presence of hydrogen, an hydrogenation catalyst, an hydroxide or alkoxide of alkaline or alkaline earth metal and less than 16% water. Eastman Chemical Company (US) 2006-01-18 EP claimed
US-20050288533-A1 PROCESSES FOR THE PREPARATION OF HIGHER MOLECULAR WEIGHT SATURATED KETONES EASTMAN CHEMICAL COMPANY 2005-12-29 US claimed
US-6979751-B2 Processes for the preparation of higher molecular weight ketones EASTMAN CHEMICAL COMPANY (US) 2005-12-27 US claimed
US-6960694-B2 Processes for preparing β-hydroxy-ketones and α,β-unsaturated ketones EASTMAN CHEMICAL COMPANY (US) 2005-11-01 US claimed
EP-1585714-A2 PROCESSES FOR THE PREPARATION OF HIGHER MOLECULAR WEIGHT KETONES EASTMAN CHEMICAL COMPANY (US) 2005-10-19 EP claimed
WO-2005028406-A2 PROCESSES FOR THE PREPARATION OF HIGHER MOLECULAR WEIGHT KETONES EASTMAN CHEMICAL COMPANY (US) 2005-03-31 WO claimed
WO-2005005361-A1 PROCESSES FOR PREPARING BETA-HYDROXY-KETONES AND ALPHA, BETA-UNSATURATED KETONES EASTMAN CHEMICAL COMPANY (US) 2005-01-20 WO claimed
US-20050004401-A1 Processes for preparing beta-hydroxy-ketones and alpha,beta-unsaturated ketones EASTMAN CHEMICAL COMPANY 2005-01-06 US claimed
US-20040122261-A1 Processes for the preparation of higher molecular weight ketones MCCUSKER-ORTH JENNIFER ELLEN (US) 2004-06-24 US claimed
US-5275843-A Manufacture of β-BaB2 O4 film by a sol-gel method NGK SPARK PLUG CO., LTD. (JP) 1994-01-04 US claimed
US-5271797-A Method for patterning metal oxide thin film ROHM CO., LTD. (JP) 1993-12-21 US claimed
JP-1069516-A None JP disclosed
EP-2258477-B1 CATALYST AND MICHAEL ADDITION REACTION PROCESS JAPAN SCIENCE & TECH AGENCY (JP) 2015-03-25 EP disclosed
EP-0300561-A2 Method for producing superconducting oxides and thin films of such oxides Koninklijke Philips Electronics N.V. (NL) 1989-01-25 EP disclosed
EP-0277020-A2 Method of preparing a superconductive material Director-General of the Agency of Industrial Science and Technology (JP) 1988-08-03 EP disclosed
US-4021480-A Process for the production of carnitine LONZA LTD. (CH) 1977-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004401-A1 Processes for preparing beta-hydroxy-ketones and alpha,beta-unsaturated ketones EBP, CYP8B1, BCKDK CYP3A4 322/4885ALDH1A1 39/4885TSHR 4352/4885
US-20040122261-A1 Processes for the preparation of higher molecular weight ketones AKR1D1, ADH1C, AKR1C2 CYP3A4 557/4885ALDH1A1 51/4885TSHR 2145/4885
US-20050288533-A1 PROCESSES FOR THE PREPARATION OF HIGHER MOLECULAR WEIGHT SATURATED KETONES GK, SKP1, TKT CYP3A4 3384/4885ALDH1A1 629/4885TSHR 4390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.